The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study

EuroIntervention 2017;12:1614-1622 published online ahead of print December 2015. DOI: 10.4244/EIJY15M12_02

1. AP-HP, Hôpital Cochin, Service de Cardiologie, Paris, France; 2. Université Paris Descartes, Université Sorbonne Paris Cité, Paris, France; 3. AP-HM, Hôpital de la Timone, Service de Cardiologie, Marseille, France; 4. Générale de Santé, Institut Cardio

Aims: In the elderly population, bare metal stents (BMS) are often preferred over drug-eluting stents (DES) because of the longer duration of dual antiplatelet therapy (DAPT) associated w

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial